Mustang Bio Inc.

News & Events

Press Releases

In The Media

1. Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement

   GlobeNewswire MAR 5, 2025 4:15 PM EST
   WALTHAM, Mass., March 05, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or ...
   READ ARTICLE

2. Mustang Bio Announces Sale of Fixed Assets and Exit of Facility

   GlobeNewswire FEB 27, 2025 4:05 PM EST
   WALTHAM, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or t...
   READ ARTICLE

3. Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement

   GlobeNewswire FEB 11, 2025 4:10 PM EST
   WORCESTER, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or...
   READ ARTICLE

4. Mustang Bio Announces Closing of $8 Million Public Offering

   GlobeNewswire FEB 10, 2025 8:00 AM EST
   WORCESTER, Mass., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or...
   READ ARTICLE

5. Mustang Bio Announces Pricing of $8 Million Public Offering

   GlobeNewswire FEB 6, 2025 7:00 AM EST
   WORCESTER, Mass., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or...
   READ ARTICLE

6. Mustang Bio Announces Reverse Stock Split

   GlobeNewswire JAN 14, 2025 8:00 AM EST
   WORCESTER, Mass., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or...
   READ ARTICLE

7. Mustang Bio Receives Positive Listing Determination from Nasdaq

   GlobeNewswire NOV 12, 2024 8:30 AM EST
   WORCESTER, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or...
   READ ARTICLE

8. Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma

   GlobeNewswire NOV 7, 2024 8:30 AM EST
   MB-108 (HSV-1 oncolytic virus) is active and well tolerated in patients with recurrent glioblasto...
   READ ARTICLE

9. Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds

   GlobeNewswire OCT 24, 2024 2:10 PM EDT
   WORCESTER, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or...
   READ ARTICLE

10. Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)

    GlobeNewswire JUN 28, 2024 8:00 AM EDT
    NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research fi...
    READ ARTICLE